Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial

OBJECTIVE: To study the efficacy and safety of low-dose oral tetrahydrocannabinol (THC) in the treatment of dementia-related neuropsychiatric symptoms (NPS). METHODS: This is a randomized, double-blind, placebo-controlled study. Patients with dementia and clinically relevant NPS were randomly assign...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neurology
Prif Awduron: van den Elsen, Geke A.H., Ahmed, Amir I.A., Verkes, Robbert-Jan, Kramers, Cees, Feuth, Ton, Rosenberg, Paul B., van der Marck, Marjolein A., Olde Rikkert, Marcel G.M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4464746/
https://ncbi.nlm.nih.gov/pubmed/25972490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001675
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg